Recent advances in Gastroenterology Cancer 2012
September 27 - 28, 2012
london , United Kingdom
Recent Advances in Gastrointestinal Cancer, in association with British Journal of Hospital Medicine and Gastrointestinal Nursing, is a prestigious conference that is primarily targeted at gastroenterologists, colorectal physicians, oncologists, surgeons and specialist nurses.
Recent Advances in Gastrointestinal Cancer will focus on the diagnosis, management and future therapies for Barrett’s oesophagus cancer, gastric cancer and colorectal cancer.
This CPD certified conference presents an excellent opportunity for all specialists within the field to update their knowledge and to interact with the specialists in the field.
Highlights of the conference will include:
• Professor Janusz Jankowski: Genetic polymorphisms and upper gastrointestinal cancer risk
• Dr Peter Watson: Chemoprevention of Barrett’s and oesophageal adenocarcinoma: AspECT
• Dr John deCaestecker: Ablation and endoscopic therapy of early oesophageal cancers
• Professor Donald McMillan: Prognostic factors for advanced gastric cancer
• Dr Gary Middleton: Reference chemotherapy regimen in advanced gastric cancer
• Mr Austin Obichere: Potential screening strategies for colorectal cancer
Benefits of attending Recent Advances in Gastrointestinal Cancer:
• Update your knowledge on screening for GI cancers, including assessment of genetic polymorphisms
• Increase understanding of the pathophysiology of Barrett’s oesophagus and cancer
• Examine the current and future therapies for Barrett’s oesophagus cancer, including chemoprevention, ablation and endoscopic therapy, and targeted therapies
• Gain insights into prognostic factors for advanced gastric cancer and explore chemotherapy, endoscopic therapies and surgical approaches to treatment
• Assess the potential screening strategies for colorectal cancer and discuss the treatment options available
• Share and exchange ideas with the lead
Recent Advances in Gastrointestinal Cancer will focus on the diagnosis, management and future therapies for Barrett’s oesophagus cancer, gastric cancer and colorectal cancer.
This CPD certified conference presents an excellent opportunity for all specialists within the field to update their knowledge and to interact with the specialists in the field.
Highlights of the conference will include:
• Professor Janusz Jankowski: Genetic polymorphisms and upper gastrointestinal cancer risk
• Dr Peter Watson: Chemoprevention of Barrett’s and oesophageal adenocarcinoma: AspECT
• Dr John deCaestecker: Ablation and endoscopic therapy of early oesophageal cancers
• Professor Donald McMillan: Prognostic factors for advanced gastric cancer
• Dr Gary Middleton: Reference chemotherapy regimen in advanced gastric cancer
• Mr Austin Obichere: Potential screening strategies for colorectal cancer
Benefits of attending Recent Advances in Gastrointestinal Cancer:
• Update your knowledge on screening for GI cancers, including assessment of genetic polymorphisms
• Increase understanding of the pathophysiology of Barrett’s oesophagus and cancer
• Examine the current and future therapies for Barrett’s oesophagus cancer, including chemoprevention, ablation and endoscopic therapy, and targeted therapies
• Gain insights into prognostic factors for advanced gastric cancer and explore chemotherapy, endoscopic therapies and surgical approaches to treatment
• Assess the potential screening strategies for colorectal cancer and discuss the treatment options available
• Share and exchange ideas with the lead
Venue
Location: Hallam Street Conference Centre
The Hallam is one of London's newest and finest conference venues. There are an abundance of rooms available for small 1 to 1 meetings or for larger events up to 250 people, these can be accommodated..
Contact
44 Hallam Street London, United Kingdon W1W 6JJ, United Kingdom london , United Kingdom
020 7706 7700
020 7706 7700
Related events
Recent advances in Gastroenterology Cancer September 27 - 28, 2012
